학술논문
The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
Document Type
Article
Author
Source
In European Neuropsychopharmacology February 2017 27(2):180-191
Subject
Language
ISSN
0924-977X